| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 73.22M | 66.80M | 67.86M | 62.57M | 59.43M |
| Gross Profit | 50.50M | 48.33M | 63.05M | 64.99M | 49.71M |
| EBITDA | 9.56M | 7.36M | 26.37M | 31.80M | 16.66M |
| Net Income | 4.90M | 3.80M | 18.07M | 21.82M | 10.47M |
Balance Sheet | |||||
| Total Assets | 1.51B | 1.52B | 1.59B | 1.74B | 1.55B |
| Cash, Cash Equivalents and Short-Term Investments | 43.45M | 166.84M | 233.79M | 407.45M | 481.96M |
| Total Debt | 105.59M | 117.48M | 152.90M | 29.12M | 29.08M |
| Total Liabilities | 1.35B | 1.37B | 1.43B | 1.58B | 1.40B |
| Stockholders Equity | 160.01M | 155.59M | 155.24M | 157.25M | 151.59M |
Cash Flow | |||||
| Free Cash Flow | 5.56M | 7.14M | 8.61M | 13.21M | 20.61M |
| Operating Cash Flow | 8.27M | 12.75M | 13.57M | 16.46M | 24.17M |
| Investing Cash Flow | 13.33M | 63.56M | -76.25M | -221.66M | -150.25M |
| Financing Cash Flow | -15.82M | -74.71M | -156.71M | 181.21M | 349.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $114.06M | 10.24 | 15.11% | 6.08% | 14.52% | 27.90% | |
72 Outperform | $114.14M | 10.26 | 8.51% | 1.81% | 12.08% | 27.88% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $129.32M | 45.90 | 1.57% | 0.88% | 9.43% | 166.36% | |
64 Neutral | $112.65M | 15.85 | 6.52% | 1.75% | 2.85% | 73.41% | |
64 Neutral | $104.62M | 16.26 | 4.68% | 3.50% | 0.99% | -16.23% | |
61 Neutral | $107.28M | 22.30 | 2.90% | 1.51% | 8.77% | 369.81% |
On January 28, 2026, Riverview Bancorp announced that its board had adopted, on January 22, 2026, a stock repurchase program authorizing the company to buy back up to $4.0 million of its common shares in the open market or through privately negotiated transactions over a period of up to 12 months, signaling a continued focus on deploying excess capital to enhance shareholder value. The board also approved the use of a Rule 10b5-1 trading plan with Keefe, Bruyette & Woods to facilitate repurchases even during blackout periods, underscoring Riverview’s intention to execute the program in a structured manner, though the company emphasized there is no guarantee on the volume of shares ultimately repurchased and it may suspend or discontinue the program at any time.
The most recent analyst rating on (RVSB) stock is a Sell with a $5.00 price target. To see the full list of analyst forecasts on Riverview Bancorp stock, see the RVSB Stock Forecast page.